News
Eli Lilly will soon launch Mounjaro KwikPen in India. This follows regulatory approval for the diabetes and obesity drug. The ...
Mounjaro is one of the bestselling weight loss drugs. See what your options are if you want to invest in Mounjaro stock.
24m
The i Paper on MSNGPs swamped by requests for NHS Mounjaro - but no one qualifiesThousands taking Mounjaro privately are inundating GP surgeries - clogging phone lines, exacerbating the 8am scramble for ...
Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...
India's drug regulator on Thursday approved the launch of pre-filled injector pens of Eli Lilly's blockbuster weight-loss drug, Mounjaro, giving the company more options to compete with rival Novo ...
8hon MSN
Exclusive: Julie Bishop lost two-and-a-half stone in eight weeks by taking Mounjaro before she was sent to hospital with ...
13h
Health and Me on MSNEli Lilly’s Mounjaro Kwikpen Gets Indian Approval For Diabetes And Weight LossEli Lilly announced that its breakthrough drug, Mounjaro (tirzepatide), has received marketing authorization from India’s ...
Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of ...
GLP-1 drugs, which have seen widespread success, have been linked to a number of cases of pancreatitis in the UK, which have ...
According to the National Family Health Survey-5 (2019–21), 24% of Indian women and 23% of Indian men are either overweight ...
20h
Futurism on MSNOzempic-Style Drugs Linked To Hundreds of Illnesses and DeathsThe UK's health regulator is investigating Ozempic and Mounjaro after linking the drugs to hundreds of severe illnesses and ...
At least 10 people have now died following side-effects allegedly caused by GLP-1 weight loss jabs. Over a million people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results